P-005 - 5 WEEKLY SESSIONS OF ADJUVANT RADIOTHERAPY’S TOXICITY IN BREAST CANCER
P-015 - ACUTE TOXICITY COMPARING HYPOFRACTIONATED RADIOTHERAPY IN BREAST CANCER
P-035 - BOOST WITH INTRAOPERATIVE RADIOTHERAPY IN UNFAVORABLE BREAST CANCER MOLECULAR SUBTYPE
P-047 - Chronic toxicity results in early-stage breast cancer using Fast-Forward
P-056 - COMPARISON BETWEEN TREATMENT OPTIONS FOR BREAST-DCIS: CLINICAL OUTCOMES AND QUALITY-OF-LIFE
P-062 - COVID19 PANDEMIC INFLUENCE ON BREAST EXTREME-HYPOFRACTIONATION IMPLEMENTATION: OUR EXPERIENCE
P-069 - Deep Inspiration Breath Hold dosimetry with VMAT in breast cancer
P-070 - DEEP INSPIRATION BREATH HOLD IN PATIENTS WITH LEFT BREAST CANCER
P-071 - DEFINING THE ROLE OF CHEST-WALL RADIOTHERAPY FOR IN-SITU BREAST CARCINOMA
P-080 - DOSIMETRIC DISTRIBUTION OF IORT-50 INTRAOPERATIVE SYSTEM
P-081 - DOSIMETRIC FEASIBILITY OF 1-WEEK-WBRT FOR SYNCHRONOUS BILATERAL EARLY BREAST CANCER
P-088 - Early experience in parciaI irradiation with IORT in one institution
P-090 - EARLY TOXICITY USING FAST FORWARD PROTOCOL AT TERTIARY HOSPITAL
P-092 - EFFICACY AND SAFETY OF ALANTEL®-CREAM IN IRRADIATION OF BREAST CANCER
P-100 - EVALUATION OF EXTREME HYPOFRACTIONATED RADIATION THERAPY IN EARLY BREAST CANCER.
P-105 - EVALUATION OF TOXICITY SECONDARY TO INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER
P-118 - Extreme hypofractionated radiotherapy (FAST-Forward): descriptive study in our centre
P-119 - EXTREME HYPOFRACTIONATION IN EARLY STAGE CANCER: OUR EXPERIENCE
P-124 - FAST-FORWARD SCHEME IN OUR CENTER AFTER THE COVID ERA
P-129 - FIRST EXPERIENCE OF INTRAOPERATIVE RADIOTHERAPY IN BREAST CANCER WITH WOMED(70KEV).
P-156 - HYPOFRACTIONATED BREAST RADIOTHERAPY FOR 1 WEEK WITH EXTERNAL RADIOTHERAPY (RHEMA)